Abstract
Background : Non-alcoholic fatty liver disease (NAFLD) is one of most important cause of fatty liver that may lead to end-stage liver disease. Various studies have reported that serum ferritin, serum uric acid and plasma malondialdehyde (MDA) levels are related to the development of NAFLD. Diabetes and obesity are the major risk factors which are associated with NAFLD. The aim of this study was assessment of serum ferritin, serum uric acid and plasma MDA levels in NAFLD patients with diabetes and with obesity. Materials and Methods : In the present study, total (n = 230) subjects were recruited for the study and divided in three groups. Group I; (n = 79) diagnosed cases of non-alcoholic fatty liver disease with diabetes, group II; (n = 91) diagnosed cases of non-alcoholic fatty liver disease with obesity patients and group III included (n = 80) healthy control subjects. Serum ferritin was measured by ELISA method. Estimation of serum uric acid was done by uricase peroxidase colorimetric method. Plasma MDA was estimated by spectrophotometric method. Results: The present study shown that serum ferritin, serum uric acid and plasma MDA levels were significantly increased (p<0.001) in NAFLD with diabetes mellitus patients (533.42±202.93, 14.29±1.87, 7.75±3.35, respectively) as compared with healthy controls (126.30±72.12, 5.19±1.72, 2.79±0.52, respectively), and also significantly increased (p < 0.001) in NAFLD with obesity patients (500.87±185.80, 12.08±2.81, 7.43±3.05, respectively) when they compared with healthy controls (126.30±72.12, 5.19±1. 2.79±0.52, respectively). Conclusion: Serum ferritin, uric acid and MDA are associated with the increasing risk for non-alcoholic fatty liver disease.
Highlights
Non-alcoholic fatty liver disease (NAFLD) is characterized the major cause of chronic liver diseases that may lead to end-stage liver disease [1]
The pathogenesis of NAFLD has not been fully understood, but it is observed that obesity, diabetes and hyperlipidemia are the major risk factors which are associated with development of non-alcoholic fatty liver disease [4, 5, 6]
In age group 41-60 years, the prevalence of diabetes and obesity with NAFLD is more in females as compare to males. 3.3 Demographic and biochemical characteristic profile of NAFLD with diabetes patients
Summary
Non-alcoholic fatty liver disease (NAFLD) is characterized the major cause of chronic liver diseases that may lead to end-stage liver disease [1]. The pathogenesis of NAFLD has not been fully understood, but it is observed that obesity, diabetes and hyperlipidemia are the major risk factors which are associated with development of non-alcoholic fatty liver disease [4, 5, 6]. Various studies have reported that serum ferritin, serum uric acid and plasma malondialdehyde (MDA) levels are related to the development of NAFLD. The aim of this study was estimation of serum ferritin, serum uric acid and plasma MDA levels in NAFLD patients with diabetes and with obesity. Conclusion: Serum ferritin, serum uric acid and plasma MDA are associated with the increased risk for non-alcoholic fatty liver disease.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Biomedical and Advance Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
